November 15, 2023
“…The S&P 500 climbed 1.9%, while the Nasdaq Composite popped about 2.4% higher. It was the best day since April for both indexes. The 30-stock Dow added nearly 490 points, or 1.4%. These gains came after October’s consumer price index, a key inflation metric, came in lower… Continue Reading…
August 15, 2023
Chinese stocks continued to slide lower on Tuesday amid further signs that the world’s second-largest economy is in retreat. Not even substantial stimulus measures from China’s central bank have been enough to fully stem the bleeding in the stock market.… Continue Reading…
November 10, 2022
“The Dow Jones Industrial Average briefly surged 900 points Thursday after the closely watched consumer price index, or CPI, inflation gauge came in cooler than expected. The 10-year Treasury yield dived to 3.87% Thursday after the cooler-than-expected CPI reading. Meanwhile,… Continue Reading…
October 17, 2022
“Home sellers are slashing their asking prices at a record clip as surging mortgage rates drive a downturn in the US housing market, according to a recent report from real estate firm Redfin. About 7.9% of home listings reported price drops during… Continue Reading…
August 15, 2022
“China’s economic slowdown deepened in July due to a worsening property slump and continued coronavirus lockdowns, with an unexpected cut in interest rates unlikely to turn things around while those twin drags remain. Retail sales, industrial output and investment all… Continue Reading…
August 15, 2022
“…Retail sales grew by 2.7% in July from a year ago, the National Bureau of Statistics said Monday. That’s well below the 5% growth forecast by a Reuters poll, and down from growth of 3.1% in June. Within retail sales,… Continue Reading…
May 10, 2022
“Bitcoin is off nearly 55% from its November peak, and 40% of holders are now underwater on their investments, according to new data from Glassnode. That percentage is even higher when you isolate for the short-term holders who got skin in the… Continue Reading…
June 28, 2021
“On Saturday, the company released interim data from the Phase 1 trial of its collaboration with Regeneron on an experimental therapy for transthyretin amyloidosis (ATTR) – a protein misfolding disorder… While it is still early days, Issi calls the data… Continue Reading…
Recent Comments